Home/ Supplements/ Probiotics/ Total YST Redux

Total YST Redux

product on market Tablet or Pill Nutri-West Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 67% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains probiotics and botanical extracts like caprylic acid and berberis aquifolium, which are researched for their antimicrobial and digestive support properties. Evidence for these specific ingredients is generally moderate to limited regarding systemic efficacy. The profile maintains a high safety score with no significant concerns noted.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Total YST Redux
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
Other Combinations
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 80.0mg (20 products) 337 studies (A:8, B:183)
Caprylic Acid
50 mg
Citrus (seed) extract
100 mg
25 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)
25 mg
Market median: 100.0mg (166 products) 11 studies (A:0, B:1)
Claims

Label Claims — Verification

Unverified All Other
Info

Product Information

Directions for Use

Directions for use: One tablet daily, or as directed.

Warnings & Precautions

TAMPER RESISTANT OUTER SEAL - DO NOT USE IF BROKEN.

DO NOT USE IF PREGNANT.

KEEP OUT OF REACH OF CHILDREN.

Formulation Notes

Contains no salt, sugar, wheat, corn, milk, yeast, soy or preservatives.

Additional Information

Manufactured under strict GMP and USP guidelines.

"When You Want The Best"

0651 MFG04/2010

Store in cool, dry place.

FOR DISTRIBUTION BY HEALTH CARE PROFESSIONALS ONLY

Product # 2710

Metadata

Product Details

DSLD Entry Date2014-01-24
Product TypeOther Combinations
FormTablet or Pill
DSLD ID28975
Data Updated2026-04-11
Research

Research Evidence

691
Research Sources
52
Avg Quality
255
Clinical Trial
205
Meta Analysis
123
Rct
81
Systematic Review
18
Cochrane Review
2
Guideline
2
Regulatory Source
1
Other
1
Narrative Review
1
Openfda Safety
A Probiotics for preventing acute upper respiratory tract infections
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Probiotics for maintenance of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for induction of remission in ulcerative colitis
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Probiotics for preventing acute upper respiratory tract infections
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Probiotics for treating eczema
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Probiotics for treating acute infectious diarrhoea
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A The Gut Microbiome in Depression and Potential Benefit of Prebiotics, Probiotics and Synbiotics: A Systematic Review of Clinical Trials and Observational Studies
Systematic Review International journal of molecular sciences 2022 PubMed DOI
A Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Probiotics to prevent infantile colic
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
View all evidence for Probiotics →
Compare

Similar Products

View all Probiotics products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.